Strength training increases maximum working capacity in patients with COPD – Randomized clinical trial comparing three training modalities  by Vonbank, Karin et al.
Respiratory Medicine (2012) 106, 557e563Available online at www.sciencedirect.com
journal homepage: www.elsevier .com/locate/rmedStrength training increases maximum working
capacity in patients with COPD e Randomized
clinical trial comparing three training modalitiesKarin Vonbank a,*, Barbara Strasser b, Jerzy Mondrzyk a,
Beatrice A. Marzluf a, Bernhard Richter a, Stephen Losch c, Herbert Nell c,
Ventzislav Petkov a, Paul Haber aaDepartment of Internal Medicine II, Medical University of Vienna, Wa¨hringer Gu¨rtel 18e20, 1090 Vienna, Austria
bUniversity of Health Sciences, Medical Informatics and Technology, Institute of Sports Medicine,
Alpine Medicine and Health Tourism, 6060 Hall in Tyrol, Austria
cWGKK Gesundheitszentrum Wien Mariahilf, Vienna, Austria
Received 4 August 2011; accepted 9 November 2011
Available online 26 November 2011KEYWORDS
Strength training;
Aerobic exercise
training;
Chronic obstructive
pulmonary disease;
Pulmonary
rehabilitation;
Exercise capacity* Corresponding author. Tel.: þ43 01
E-mail address: karin.vonbank@me
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2011.11.005Summary
Background and objective: Skeletal muscle dysfunction contributes to exercise limitation in
patients with chronic obstructive pulmonary disease (COPD). Strength training increases
muscle strength and muscle mass, but there is an ongoing debate on the additional effect
concerning the exercise capacity. The purpose of this study was to compare the effects of
three different exercise modalities in patients with COPD including endurance training
(ET), progressive strength training (ST) and the combination of strength training and endur-
ance training (CT).
Design: A prospective randomized trial.
Methods: Thirty-six patients with COPD were randomly allocated either to ET, ST, or CT.
Muscle strength, cardiopulmonary exercise testing, lung function testing and quality of life
were assessed before and after a 12-week training period.
Results: Exercise capacity (Wmax) increased significantly in all three training groups with
increase of peak oxygen uptake (VO2peak) in all three groups, reaching statistical significance
in the ET group and the CT group. Muscle strength (leg press, bench press, bench pull)
improved in all three training groups, with a higher improvement in the ST (þ39.3%,
þ20.9%, þ20.3%) and the CT group (þ43.3%, þ18.1%, þ21.6%) compared to the ET group
(þ20.4%, þ6.4%, þ12.1%).40400 4774; fax: þ43 01 40400 4784.
duniwien.ac.at (K. Vonbank).
1 Elsevier Ltd. All rights reserved.
558 K. Vonbank et al.Conclusions: Progressive strength training alone increases not only muscle strength and
quality of life, but also exercise capacity in patients with COPD, which may have implications
in prescription of training modality.
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Chronic obstructive pulmonary disease (COPD) is a progres-
sive disorder that leads to substantial morbidity and
mortality. Treatment goals in COPD are prevention or
deceleration of progression and increasing patients‘ quality
of life.1 Limitation of exercise capacity is a significant
variable related to poor disease prognosis.1e3
Endurance and strength training are both essential
components of pulmonary rehabilitation in patients with
COPD.4e7 There is, however, anongoingdebateontheoptimal
exercise protocol. Several studies have compared different
training modalities and training intensities in patients with
COPD, but there is substantial variation concerning the
durationof training sessions and the results of improvement in
muscle strength and exercise capacity. Endurance training is
a key component of pulmonary rehabilitation and leads to
clinically significant improvement inexercise performance.8,9
Low-intensity and high-intensity exercise training are both
effective in patients with COPD with a tendency for greater
benefits after higher training intensity.10 The optimal training
duration for COPD patients with different impairment of
exercise capacity is still unclear.11
Peripheral limb muscle strength is significantly reduced
in COPD patients compared to normal subjects.12 Muscle
strength strongly correlates with symptom intensity and
work capacity.13,14 Despite the increasingly recognised role
of skeletal muscle dysfunction in patients with COPD12e15
there are still conflicting results concerning the additional
improvement attained with strength training.11 Resistance
training enhanced peripheral muscle force, muscle endur-
ance and whole- body endurance in COPD patients5,16e19
without significantly increasing peak exercise capacity. A
combination of endurance training and strength training
can lead to a significant improvement in endurance exer-
cise time, muscle strength and quality of life, but does not
seem to be more effective than endurance training
alone.4,6,20 Studies comparing all three training modalities
are rare and differ in the duration of endurance training
and the intensity of strength training.6,21,22
The aim of this study was to compare the effects of
endurance training, progressive strength training and
a combination of both endurance and strength training on
the functional adaptations in COPD patients.Methods
A prospective randomized study design was utilized. All
patients performed a lung function test, a cardiopulmonary
incremental exercise test, muscle strength test, quality of
life assessment and a three-month training program
according to randomization.Subjects
Stable outpatients with COPD were considered for this
study. COPD was diagnosed according to the GOLD
consensus. Patients with evidence of other concomitant
lung diseases or other cardiovascular disorders were
excluded. Other exclusion criteria were any pathology
which could possibly interfere with the ability to perform
exercise. Based on these inclusion and exclusion criteria
forty-three patients were included in the study, 7 patients
ceased training due to acute exacerbation. Thirty-six
patients (11 women and 25 men) completed the study.
According to the GOLD criteria, 4 patients were categorised
as GOLD stage I, 14 patients as stage II, 16 patients as stage
III and 2 patients as stage IV. All 36 patients were receiving
inhaled ß-agonists, 17 were receiving inhaled corticoste-
roids, 2 were on oral theophylline. Smoking habits were not
significantly different between all three training groups. 12
patients were randomly assigned to the endurance training
group, 12 patients to the strength training group and 12
patients to a group with combined endurance and strength
training. In the endurance training group there was 1
patient in GOLD stage I, 6 patients in stage II, 4 patients in
stage III and 1 patient in stage IV. In the strength training
group there was 1 patient in stage I, 5 in stage II, 5 in stage
III and 1 in stage IV. In the combined training group there
were 2 patients in stage I, 3 in stage II and 7 in stage III.
There was no difference with respect to GOLD stage
between the three training groups.
This study was approved by the Ethics Committee of the
Medical University of Vienna. All patients gave their
informed consent.
Pulmonary function testing
Before exercise, each patient underwent routine lung
function studies. Predicted normal values were derived
from the reference values of the Austrian Society of
Pulmonary Medicine 23 which is in accordance with the ERS
recommendations.24 Each value represents the best of at
least three measurements. Spirometry and whole-body
plethysmography were performed with the Autobox DL
6200 (Sensor Medics, Vienna Austria) and blood gas was
measured with the gas analyzer (model ABL 510, Radiom-
eter, Copenhagen, Denmark). The results were expressed
as absolute values and as percent of the predicted values.
Incremental exercise test
In order to determine the individual working capacity and
peak oxygen uptake (VO2peak), a symptom-limited
maximal incremental cycle exercise test with gas
exchange measurements was performed. The load was
Strength training and COPD 559increased every 2 min until maximum working capacity was
reached, until exhaustion. Exhaustion was determined at
the point where the subject was unable to sustain
a pedaling rate of 60 rpm. The increment was adapted in
order to guarantee at least four but no more than six steps
and varied from 5 to 15 W, depending on the maximum
working capacity. Pedaling rate was constant at 60e70/
min.
Maximum working capacity (Wmax) was calculated as
a percentage of predicted value depending on age, gender,
and body surface.25 ECG was continuously monitored during
CPET. The variables measured at each step and at
maximum working capacity were blood pressure and
minute ventilation (VE). Oxygen uptake (VO2) and CO2
output (VCO2) were measured using the breath-by- breath
method (Sensormedics 2900 Metabolic Measurement Cart).
Parameters relevant for maximum exercise were VO2peak
and Wmax.Training program
Strength training (ST)
Strength training was performed two times per week
including eight different exercises per session. During the
first two weeks, the weight was kept to a minimal level so
that the patients could learn the exercise techniques, and
to allow the muscles to adapt to the training as well as to
prevent muscle soreness and joint pains. From the third
week two sets per muscle group per week were performed.
One set consisted of 8e15 repetitions without interruption,
until severe fatigue occurred and completion of further
repetitions was impossible. The training load was individ-
ually and systematically adapted to keep the maximum
possible repetitions per set between 8 and 15. When more
than 15 repetitions were successfully performed at a given
weight, the weight was increased by an amount that
permitted approximately ten repetitions to be performed.
The numbers of sets for each muscle group were system-
atically increased every 4 weeks from 2 at the beginning of
the program to 3 and finally 4 sets per week at the end of
the program. The ST program consisted of exercises for
major muscle groups. Exercises to strengthen the upper
body included bench press (pectoralis), chest cross (hori-
zontal flexion of the shoulder joint), shoulder press
(trapezius), pull downs (latissimus dorsi), bicep curls, tri-
cep extensions and exercises for abdominal muscles (sit-
ups). Lower body exercises included leg press (quadriceps
femoris).
Endurance training (ET)
Systematic ET was performed on a cycle ergometer, two
times per week. During the first 4 weeks, participants
trained for 20 min per session. Exercise sessions were
increased by 5 min every four weeks. The total exercise
time per week, during the last four weeks, excluding warm
up and cool down, was 60 min. Heart rate (HR) was moni-
tored continuously throughout the training period (POLAR
Electro, Kempele, Finland). Cycle ergometer load during
training session was adjusted according to the heart rate
response of each patient, to a level corresponding to 60% of
VO2peak. This was derived from ergometry by using thefollowing formula (Karvonen26): HRZ HRrestþ (HRmax
HRrest) 0.6 5 beats/min, where HRrest was HR after
a break of ten minutes, in supine position.
Strength training and endurance training (CT)
Patients in the combined training group performed endur-
ance training plus strength training program as described
above two times per week.
Quality of life assessment
Health-related quality of life was assessed by St. George
Respiratory Questionnaire, consisting of an impact score,
activity score, and symptoms score, as well as a total score.
Each score ranges from 0 to 100, with lower values indi-
cating a better quality of life.
Data analysis
A sample size of 12 patients each group was calculated to
provide a power of 80% (alphaZ 0.05) to detect a differ-
ence in the training- induced changes of parameters
between groups of 6% (assuming a standard deviation of
5%).
Continuous data are expressed as mean SD. Differ-
ences of variables over time were evaluated using the
paired Student t-test. Differences between groups were
analyzed using a one-way analysis of variance (ANOVA) and
post hoc Tukey’s multiple-comparison test. A value of
p< 0.05 (2-tailed) was considered statistically significant.
Statistical analyses were carried out using the statistical
software package SPSS 12.0 (SPSS Inc., Chicago, USA).
Results
Forty-three patients with COPD were included in the study
and randomized to ET, ST or CT. Thirty-six patients
completed the study. Baseline parameters for all three
training groups are shown in Table 1. The mean age of the
patients was 60.2 6.5 years. The mean FEV1 of all patients
was 1.8 0.4 l with a ratio of FEV1 to FVC of 51.4 12.9%.
No significant differences in respect of lung function
parameters were seen between the training groups.
Cardiopulmonary exercise test at baseline
No significant differences in baseline Wmax were found
between groups (Table 2). Wmax at baseline was
62.9 13.4% in the ET, 63.2 11.7% in the ST and
57.1 21.2% in the CT. VO2peak in the ET at baseline was
72.9 16.9%, 73.6 8.9% in the ST and 62.3 15.8% in the
CT. No significant differences concerning maximal lactate
increase, maximal heart rate, minute ventilation or blood
gas analysis were detected between the training groups at
baseline.
Cardiopulmonary exercise test after training period
Maximum exercise capacity improved significantly in all
three training groups (Fig. 1). It increased from
Table 1 Subject demographics and pulmonary function at baseline.
Mean SD Mean SD Mean SD Mean SD
All patients Endurance training Strength training Combined training
nZ 36 nZ 12 nZ 12 nZ 12
Age (yr) 60.2 6.5 61.8 5.4 60.0 6.4 59.2 7.7
Gender
Female 11 4 4 3
Male 25 8 8 9
BMI (kg/m2) 27.4 6.1 26.2 4.4 27.4 7.6 28.2 8.4
Weight (kg) 80.8 20.2 77.8 14.9 80.8 17.8 82.9 20.2
Height (cm) 171 10 172 10 171 10 170 10
VC (L) 3.5 0.7 3.5 0.4 3.3 0.7 3.6 1.0
FEV1 (L) 1.8 0.4 1.8 0.4 1.9 0.4 1.6 0.5
FEV1/FVC (%) 51.4 12.9 51.6 14.3 56.5 9.3 47.0 13.6
FEV1 (%pred.) 55.8 16.4 58.1 19.3 58.3 15.5 51.1 20.3
TLC (% predicted) 116 27 115 39 111 13 123 23
RV/TLC (%) 48.7 8.3 50.5 8.4 48.0 8.8 48.6 9.4
DLCO% predicted 67.7 22.3 69.8 21.4 66.5 13.5 67.2 28.1
PaO2 (mmHg) 71.8 9.8 71.6 8.0 68.2 7.4 69.7 10.6
PaCO2 (mmHg) 38.1 3.1 38.1 3.2 38.8 3.2 37.8 3.6
IC (L) 2.6 0.6 2.8 0.4 2.4 0.5 2.7 0.7
MVV (L/min) 69.0 18.6 70.7 20.4 69.6 13.8 66.3 21.4
Smoking habits (py) 28.9 8.8 29.7 9.2 27.4 9.3 28.4 9.3
BMI, body mass index; VC, vital capacity; FEV1, forced expiratory volume in one second; FEV1/FVC, forced expiratory volume in one
second%vital capacity; TLC, total lung capacity; RV/TLC, residual volume%total lung capacity; DLCO, diffusing capacity of the lung for
carbon monoxide; PaO2, partial arterial oxygen pressure; PaCO2, partial arterial carbon dioxide pressure; IC, inspiratory capacity; MVV,
maximum voluntary ventilation.
560 K. Vonbank et al.62.9 13.4% to 69.3 12.0% (p< 0.005) in the ET, from
63.2 11.7% to 69.2 12.1% in the ST (p< 0.004) and from
57.1 21.2% to 64.5 20.3% in the CT (p< 0.006). The
VO2peak significantly improved in the ET from 72.9 16.9%
to 79.2 21.3% (p< 0.04) and in the CT from 62.3 15.8%
to 68.8 19.7%, p< 0.02 (Table 2). In the ST the VO2peak
improved after training period without reaching statistical
significance (from 73.6 8.9% to 76.3 12.9%, pZ 0.27).
The maximum lactate increase was greater after the
training period in the ST and the CT, but only reached
statistical significance in the ST (pZ 0.02). Ventilatory
equivalent for oxygen decreased significantly at the same
submaximal work rate after training period in all three
training groups, reaching statistical significance in the ET
and the CT. Heart rate at submaximal exercise decreased
significantly in all three training groups (Table 2). No
significant differences were seen in pulmonary gas
exchange and maximal heart rate in all three groups before
and after the training period.
Strength measurement at baseline
The maximum muscle strength for leg press was
82.1 26.6 kg in the ET, 84.6 25.9 kg in the ST and
97.9 24.1 kg in the CT at baseline without statistically
significant differences. The maximum muscle strength for
bench press was 41.3 12.9 kg in the ET, 44.3 15.8 kg in
the ST and 49.3 15.2 kg in the CT. Maximum muscle
strength for bench pull was 46.5 15.3 kg in the ET,
49.6 16.5 kg in the STand49.4 11.6 kg in theCT (Table3).Strength measurements and health-related quality
of life after training period
Muscle strength (leg press, bench press and bench pull)
improved in all three training groups (Fig. 2) with a signifi-
cant higher improvement in the ST (þ39.3 27.7%,
þ20.9 19.8%, þ20.3 10.3%) and the CT (þ43.3 40.2%,
þ18.1 12.4%, þ21.6 26.6%) compared to the ET alone
(þ20.4 32.3%, þ6.4 16.3%, þ12.1 15.5%). Health-
related quality of life improved significantly in all three
training groups (total score, p< 0.01), with a tendency to
a greater improvement in the CT group (Table 3).Discussion
In this study comparing three different training modalities
in patients with COPD, strength training alone increased
the maximum exercise capacity to a similar extent as
endurance training and combined endurance and strength
training with significant increase of muscle strength.
Moreover, a significant decrease of heart rate and ventila-
tory parameters at submaximal exercise levels could be
shown not only after endurance training and the combined
training, but also after strength training alone, which
confirm, that an effective strength training not only
increase muscle strength, but also improve work efficiency.
Peak oxygen uptake increased in all three training groups
reaching statistical significance in the endurance and the
combined training group. In prior studies, improvement of
Table 2 Physiologic parameters at exercise before and after different training modalities.
Endurance training Strength training Combined training
Baseline End 12-week
training
Baseline End 12-week
training
Baseline End 12-week
training
Wattmax (Watt) 89.2 20.2 98.2 22.1** 91.9 19.8 101.0 22.6** 88.0 37.3 98.8 38.6*
Wmax (%pred.) 62.9 13.4 69.3 12.0** 63.2 11.7 69.2 12.1** 57.1 21.2 64.5 20.3**
VO2 (%pred.) 72.9 16.9 79.2 21.3* 73.6 8.9 76.3 12.9 62.3 15.8 68.8 19.7*
VO2 (ml/kg/min) 18.4 4.8 20.4 6.7* 18.2 2.1 18.8 2.9 15.7 3.4 17.4 4.9*
VE/VO2max
VE/VO2submax
43.3 11.3
36.4 7.1
42.3 7.3
33.1 5.5**
43.5 7.5
36.6 8.9
41.2 7.2
33.9 7.0
46.1 8.7
39.4 5.3
45.9 6.2
36.8 5.5**
VE/VCO2max
VE/VCO2submax
39.4 8.9
40.8 5.3
37.2 5.3
37.1 5.1*
39.4 5.5
39.8 6.8
37.9 7.1
38.3 5.3
44.3 7.3
44.8 4.9
43.5 6.0
43.0 4.9
Lactat (mmol/L) 3.8 1.7 4.2 1.5 3.9 1.5 4.9 1.6* 3.2 1.6 4.4 2.0
Vtmax (l)
Vtsubmax (l)
1.8 0.4
1.4 0.3
1.7 0.3
1.4 0.3
1.8 0.3
1.4 0.3
1.77 0.4
1.3 0.3
1.8 0.5
1.5 0.3
1.71 0.6
1.4 0.3
VEmax (L)
VEsubmax (L)
57.9 14.4
27.8 5.7
57.9 13.6
26.4 4.0
59.9 8.0
30.4 7.9
60.0 11.9
25.4 4.4*
59.1 18.0
28.7 5.6
63.2 18.6
27.5 6.2
F max (breaths/min)
F submax (breaths/min)
35.7 10.2
20.8 4.5
34.3 6.7
20.1 5.8
34.3 6.9
22.0 5.7
34.1 3.9
20.0 6.8
36.7 9.9
21.6 4.1
38.0 10.3
20.0 5.5
HR (beats/min)
HR submax (beats/min)
145 26
109 17
147 25
101 14**
133 13
104 13
135 12
95 8*
136 29
102 14
135 15
98 13*
Data are expressed as mean SE.
Significant difference between baseline and end 12-week training: *p< 0.05, **p< 0.01.
Wmax, maximum working capacity; VO2, peak oxygen uptake; VE/VO2max, ventilatory equivalent for oxygen at maximum exercise, VE/
VO2submax, ventilatory equivalent for oxygen at submaximal exercise; VE/VCO2max, ventilatory equivalent for carbon dioxide at
maximum exercise; VE/VCO2submax, ventilatory equivalent for carbon dioxide at submaximal exercise; Vt max, tidal volume at
maximum exercise; Vtsubmax, tidal volume at submaximal exercise; VEmax, maximum minute ventilation; VEsubmax, minute venti-
lation at submaximal exercise; F max, breath per minutes at maximum exercise; F submax, breath per minutes at submaximal exercise;
HR max, heart rate at maximum exercise; HR submax, heart rate at submaximal exercise.
Strength training and COPD 561maximum exercise capacity after strength training could
only be shown by Spruit et al.20 after a 12-week training
period, where the patients were given the opportunity to
attend 36 sessions. In our study the patients attended only
24 sessions at all. A study by Ortega et al.6 comparedFigure 1 Increase in maximum working capacity after
strength training (ST), endurance training (ET) and combined
strength and endurance training (CT).endurance training consisting of 40 min three times per
week at 60% of Wmax and strength training consisting of
five different exercises with 6e8 repetitions at 70e85% of
one repetition maximum and a combined training group
with half of the endurance and strength program for
a training period of 12-weeks. This study revealed that
a significant improvement of peak oxygen uptake and
maximum exercise capacity could only be shown in the
endurance group, whereas muscle strength and endurance
time could be improved in all three training groups. Mador
et al.7 did not observe a significant increase in maximum
workload and peak oxygen uptake after either endurance
training 20 min three times per week or combined endur-
ance and strength training. In our study, the patients per-
formed the same amount of endurance training in the
combined group as those in the endurance group. Inter-
estingly, despite a much shorter endurance training time in
our study compared to Ortega et al.,6 the measured extent
of improvement in maximum exercise capacity after
endurance training is similar. Several studies compared
different training intensities and modalities,10,11 but the
endurance training time varied widely in most studies.
Despite these variations in endurance training time per
week, an increase in exercise capacity could be seen in
most of the studies. The minimum relevant endurance
training time to improve exercise capacity in COPD patients
has not yet been established, but our study shows that even
starting with an endurance training time of only 20 minutes
twice per week in the first month with an increase of 10
Table 3 Muscle strength and health-related quality of life before and after different training modalities.
Endurance training Strength training Combined training
Baseline End 12-week
training
Baseline End 12-week
training
Baseline End 12-week
training
Leg press (1RM kg) 82.1 26.6 94.9 26.1 84.6 25.9 115.6 32.9** 97.9 24.1 136.2 40.3**
Bench press (1RM kg) 41.3 12.9 43.6 13.1 44.3 15.8 53.3 19.2** 49.3 15.2 58.3 19.0**
Bench pull (1RM kg) 46.5 15.3 50.3 15.5* 49.6 16.5 59.5 20.4** 49.4 11.6 61.0 24.1*
Total score 27.9 15.7 19.1 14.6** 42.3 14.8 30.1 13.2** 40.7 11.9 31.6 15.7**
Impact score 17.9 13.1 10.7 11.4 34.7 18.9 21.1 14.7* 33.0 12.0 25.1 15.3*
Activity score 38.8 21.0 26.9 21.4* 48.6 13.9 39.7 14.3* 49.9 16.3 38.7 18.8**
Symptom score 40.3 20.6 24.4 20.8** 54.9 22.4 41.4 16.6* 48.5 21.1 38.9 25.7*
Data are expressed as mean SE.
*p-value< 0.05,**p-value< 0.01.
562 K. Vonbank et al.minutes every 4 weeks up to 40 minutes per week for the
last 4 weeks and a total amount of 24 training sessions leads
to a significant improvement of exercise capacity. Maximal
lactate at peak exercise increased in all three training
groups according to the increase in maximum exercise
capacity, reaching statistical significance only in the
strength training group.
Health-related quality of life as measured using St.
George Respiratory Questionnaire (SGRQ) improved signifi-
cantly in all three training groups with a greater improve-
ment of the activity score in the combined training group.
No significant changes in lung function parameters could be
shown after training, which is in line with previous studies.
Muscle strength increased in all three training groups
with a significantly higher improvement in the ST and CT
group. The extent of improvement was similar to that
achieved in previous studies of patients with COPD.
Strength training was well-tolerated, and no injuries
occurred during training.
The limitations of our study are the small number of
patients per group and the lack of data concerning
submaximal exercise tests, which could be already shown
to improve even more after exercise training than
a symptom-limited maximum exercise test in these
patients. The duration of the endurance training is quiteFigure 2 Increase in muscle strength after strength training
(ST), endurance training (ET) and combined strength and
endurance training (CT).short comparing to other studies, but effective which could
be shown by similar improvement in maximum exercise
capacity and oxygen uptake compared to others6 and
decrease in submaximal heart rate and ventilatory param-
eters after the training period. The patients in the
combined training group showed a more severe impairment
of lung function compared to the other groups, which could
possibly interfere with the training results, but these
differences between groups did not reach statistical
significance.
Impaired exercise tolerance is common even in early
COPD stages. Exercise training is an essential component of
pulmonary rehabilitation in patients with COPD. Maximum
oxygen uptake and muscle strength are both independent
factors associated with decreased survival rates. Whereas
endurance and strength training programs are strongly
scientific based in the last years, the optimal training
duration and intensity is still not established.
In our study, a time sparing training programwith strength
training alone is capable to significantly improve exercise
capacity and muscle strength, which could have some
implication in training prescription in patients with COPD.Author contributions
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